G. Rohde (Frankfurt am Main, Germany), S. Sperling Haugen (Aarhus N, Denmark)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up B. Vijayakumar (London, United Kingdom), J. Tonkin (London, United Kingdom), A. Devaraj (London, United Kingdom), K. Philip (London, United Kingdom), C. Orton (London, United Kingdom), S. Desai (London, United Kingdom), P. Shah (London, United Kingdom)
|   |
Post-discharge persistent symptoms after hospitalization for COVID-19 M. Jebali (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), H. Snene (Tunis, Tunisia), D. Belkhir (Tunis, Tunisia), M. Maalej (Tunis, Tunisia), S. Kerkeni (Tunis, Tunisia), M. Trabelsi (Tunis, Tunisia), A. Laater (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
|   |
Predicting factors of pulmonary functional sequelae in COVID-19 patients after 4 months from hospital admission A. Frizzelli (Parma, Italy), M. Aiello (Parma, Italy), L. Calzetta (Parma, Italy), P. Mori (Parma, Italy), L. Marchi (Parma, Italy), V. Alfieri (Parma, Italy), N. Sverzellati (Parma, Italy), M. Majori (Parma, Italy), A. Chetta (Parma, Italy)
|   |
Mental disorders in patients (pts) with COVID-19 pneumonia:comparison with COPD exacerbation Y. Huba (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), O. Shchudro (Dnipro, Ukraine), N. Sanina (Dnipro, Ukraine)
|   |
Influence of COVID-19 pneumonia on development of mental disorders Y. Huba (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), O. Shchudro (Dnipro, Ukraine), N. Sanina (Dnipro, Ukraine)
|   |
Respiratory Physiological Sequelae following Coronavirus Infection: A Systematic Review C. Huntley (Birmingham, United Kingdom), K. Patel (Birmingham, United Kingdom), S. Bushra (Birmingham, United Kingdom), F. Mobeen (Birmingham, United Kingdom), P. Burge (Birmingham, United Kingdom), A. Turner (Birmingham, United Kingdom), G. Walters (Birmingham, United Kingdom)
|   |
Peculiar high resolution computed tomography patterns in post-covid fibrosis R. Tyagi (Lucknow (UP), India), S. Kant (Lucknow (UP), India), D. Bajaj (Lucknow (UP), India), A. Parihar (Lucknow (UP), India)
|   |
Quality of life of patients three months after COVID-19 hypoxemic pneumonitis H. Snène (Tunis, Tunisia), I. El Wadhane (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), S. Kerkeni (Tunis, Tunisia), M. Trabelsi (Tunis, Tunisia), W. Fenina (Tunis, Tunisia), M. Maalej (Tunis, Tunisia), A. Jebali (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
|   |
Post-COVID impairment: objective multidimensional assessment of long term effects in hospitalized, non-ICU patients E. Cardoso (Basel, Switzerland), A. Darie (Basel, Switzerland), M. Herrmann (Basel, Switzerland), D. Schumann (Basel, Switzerland), L. Grize (Basel, Switzerland), W. Strobel (Basel, Switzerland), K. Jahn (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
|   |
Predictors of mental health disorders in health workers during COVID-19 pandemic R. Jebali (ARIANA, Tunisia), A. Ben Mansour (ARIANA, Tunisia), S. Ben Saad (ARIANA, Tunisia), H. Daghfous (ARIANA, Tunisia), F. Tritar (ARIANA, Tunisia)
|   |
Insomnia in COVID-19 survivors: prevalence, severity and associated factors W. JELASSI (TUNIS, Tunisia), A. Hedhli (TUNIS, Tunisia), C. Echeikh (TUNIS, Tunisia), M. Mjid (TUNIS, Tunisia), Y. Ouahchi (TUNIS, Tunisia), S. Merai (TUNIS, Tunisia), S. Toujani (TUNIS, Tunisia), B. Dhahri (TUNIS, Tunisia)
|   |
LOTUS - Long-term pulmonary outcomes after infection with SARS-CoV-2:Dyspnea is poorly explained by reduced lung function S. Haugen (Aarhus, Denmark), A. Fløe (Aarhus, Denmark), S. Leth (Aarhus, Denmark), T. Gissel (Viborg, Denmark), L. Kristensen (Holstebro, Denmark), C. Hyldgaard (Silkeborg, Denmark), L. Dahl (Randers, Denmark), A. Topcu (Horsens, Denmark), J. Schmid (Aarhus, Denmark), S. Jensen-Fangel (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark)
|   |
Radiologic follow-up after COVID-19 pneumonia E. Cocconcelli (Padova (PD), Italy), N. Bernardinello (Padova (PD), Italy), C. Giraudo (Padova (PD), Italy), A. Giorgino (Padova (PD), Italy), D. Leoni (Padova (PD), Italy), S. Marinello (Padova (PD), Italy), S. Lococo (Padova (PD), Italy), G. Castelli (Padova (PD), Italy), M. Saetta (Padova (PD), Italy), A. Cattelan (Padova (PD), Italy), P. Spagnolo (Padova (PD), Italy), E. Balestro (Padova (PD), Italy)
|   |
First insight into the complexity of post-covid recovery - a single centre experience M. Banic (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), D. Muršic (Zagreb, Croatia), Z. Boras (Zagreb, Croatia), V. Trkeš (Zagreb, Croatia), D. Baricevic (Zagreb, Croatia), M. Koršic (Zagreb, Croatia), M. Juricic Kursan (Zagreb, Croatia), T. Jalušic Gluncic (Zagreb, Croatia), L. Basara (Zagreb, Croatia), M. Jankovic Makek (Zagreb, Croatia)
|   |
Development of asthma-related symptoms in mild or moderate COVID-19 patients several months post infection: A descriptive case series from a pneumologist outpatient clinic M. Marchon (Gurmels/Laupen, Switzerland), A. Stieger (Gurmels/Laupen, Switzerland), S. Wittmer (Gurmels/Laupen, Switzerland)
|   |
Patterns of dyslipidaemia in postCOVID19 follow up patients; food for thought I. Bracka (Athens, Greece), E. Keramida (Athens, Greece), E. Bellou (Athens, Greece), I. Machairas Sallas (Athens, Greece), I. Karampinis (Athens, Greece), T. Daskalos (Athens, Greece), S. Mazarakis (Athens, Greece), P. Demertzis (Athens, Greece), V. Papagiannopoulou (Athens, Greece), G. Hardavella (Athens, Greece)
|   |
Trajectory of patient-reported outcomes (PROMs) up to 6 months after hospitalization for SARS-CoV-2 J. Berentschot (Rotterdam, Netherlands), L. Bek (Rotterdam, Netherlands), S. Huijts (Rotterdam, Netherlands), H. Van Den Berg-Emons (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands)
|   |
Depression, anxiety, traumatic stress and burnout in healthcare workers (HCWs) during the COVID-19 pandemic in Greece:a multi-center, cross-sectional study N. Athanasiou (Athens, Greece), S. Pappa (London, United Kingdom), S. Patrinos (Athens, Greece), Z. Barmparessou (Athens, Greece), S. Tsikrika (Athens, Greece), A. Adraktas (Athens, Greece), A. Pataka (Thessaloniki, Greece), I. Migdalis (Athens, Greece), S. Gida (Trikala, Greece), P. Katsaounou (Athens, Greece)
|   |
Pulmonary function and tomographic features of COVID-19 survivors 2 months after hospital discharge: a cohort study N. Visconti (Rio de Janeiro, Brazil), M. Cailleux-Cezar (Rio de Janeiro, Brazil), B. Bracarense (Rio de Janeiro, Brazil), F. Amorim (Rio de Janeiro, Brazil), F. Silva (Rio de Janeiro, Brazil), N. Graça (Rio de Janeiro, Brazil), L. Loivos (Rio de Janeiro, Brazil), D. Capone (Rio de Janeiro, Brazil), M. Santos (Rio de Janeiro, Brazil), A. Cardoso (Rio de Janeiro, Brazil), F. Mello (Rio de Janeiro, Brazil)
|   |
Symptoms and quality of life in Finnish COVID-19 survivors – women more symptomatic after six months A. Lindahl (Helsinki, Finland), M. Aro (Helsinki, Finland), J. Reijula (Helsinki, Finland), M. Mäkelä (Helsinki, Finland), J. Ollgren (Helsinki, Finland), M. Puolanne (Helsinki, Finland), A. Järvinen (Helsinki, Finland), T. Vasankari (Helsinki, Finland)
|   |